» Articles » PMID: 30659980

Absence of an Osteopetrosis Phenotype in IKBKG (NEMO) Mutation-positive Women: A Case-control Study

Abstract

Background: NF-κB essential modulator (NEMO), encoded by IKBKG, is necessary for activation of the ubiquitous transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). Animal studies suggest NEMO is required for NF-κB mediated bone homeostasis, but this has not been thoroughly studied in humans. IKBKG loss-of-function mutation causes incontinentia pigmenti (IP), a rare X-linked disease featuring linear hypopigmentation, alopecia, hypodontia, and immunodeficiency. Single case reports describe osteopetrosis (OPT) in boys carrying hypomorphic IKBKG mutations.

Method: We studied the bone phenotype in women with IP with evaluation of radiographs of the spine and non-dominant arm and leg; lumbar spine and femoral neck aBMD using DXA; μ-CT and histomorphometry of trans-iliac crest biopsy specimens; bone turnover markers; and cellular phenotype in bone marrow skeletal (stromal) stem cells (BM-MSCs) in a cross-sectional, age-, sex-, and BMI-matched case-control study. X-chromosome inactivation was measured in blood leucocytes and BM-MSCs using a PCR method with methylation of HpaII sites. NF-κB activity was quantitated in BM-MSCs using a luciferase NF-κB reporter assay.

Results: Seven Caucasian women with IP (age: 24-67 years and BMI: 20.0-35.2 kg/m) and IKBKG mutation (del exon 4-10 (n = 4); c.460C>T (n = 3)) were compared to matched controls. The IKBKG mutation carriers had extremely skewed X-inactivation (>90:10%) in blood, but not in BM-MSCs. NF-κB activity was lower in BM-MSCs from IKBKG mutation carriers (n = 5) compared to controls (3094 ± 679 vs. 5422 ± 1038/μg protein, p < 0.01). However, no differences were identified on skeletal radiographics, aBMD, μ-architecture of the iliac crest, or bone turnover markers. The IKBKG mutation carriers had a 1.7-fold greater extent of eroded surfaces relative to osteoid surfaces (p < 0.01), and a 2.0-fold greater proportion of arrested reversal surface relative to active reversal surface (p < 0.01).

Conclusion: Unlike mutation-positive males, the IKBKG mutation-positive women did not manifest OPT.

Citing Articles

Incontinentia pigmenti with intracranial arachnoid cyst: A case report.

Li W, Li M, Ding J, Wang L, Wang S, Wang Y World J Clin Cases. 2022; 10(23):8352-8359.

PMID: 36159532 PMC: 9403704. DOI: 10.12998/wjcc.v10.i23.8352.


Critical Roles of NF-κB Signaling Molecules in Bone Metabolism Revealed by Genetic Mutations in Osteopetrosis.

Jimi E, Katagiri T Int J Mol Sci. 2022; 23(14).

PMID: 35887342 PMC: 9322175. DOI: 10.3390/ijms23147995.

References
1.
Abdallah B, Haack-Sorensen M, Fink T, Kassem M . Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone. 2006; 39(1):181-8. DOI: 10.1016/j.bone.2005.12.082. View

2.
Guerrini M, Sobacchi C, Cassani B, Abinun M, Kilic S, Pangrazio A . Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet. 2008; 83(1):64-76. PMC: 2443850. DOI: 10.1016/j.ajhg.2008.06.015. View

3.
Hirata-Tsuchiya S, Fukushima H, Katagiri T, Ohte S, Shin M, Nagano K . Inhibition of BMP2-induced bone formation by the p65 subunit of NF-κB via an interaction with Smad4. Mol Endocrinol. 2014; 28(9):1460-70. PMC: 5414795. DOI: 10.1210/me.2014-1094. View

4.
Conte M, Pescatore A, Paciolla M, Esposito E, Miano M, Lioi M . Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease. Hum Mutat. 2013; 35(2):165-77. DOI: 10.1002/humu.22483. View

5.
MIGEON B, Axelman J, de Beur S, Valle D, Mitchell G, Rosenbaum K . Selection against lethal alleles in females heterozygous for incontinentia pigmenti. Am J Hum Genet. 1989; 44(1):100-6. PMC: 1715454. View